Global Live Cell Imaging Market: Key Developments
In July 2021, Becton, Dickinson and Company announced the launch of bdbiosciences.com web and e-commerce site, a digital marketplace to enhance online purchase of BD research solutions including clinical and single-cell multiomic products.
In January 2021, ZEISS GROUP announced the launch of ZEISS Visioner 1, an innovative digital microscope that facilitates all-in-one focus in real time through its Micro-mirror Array Lens System (MALS), simplifying the imaging process and delivering higher throughput.
In August 2021, CytoSMART Technologies announced the launch of CytoSMART Lux3 BR, a new bright field live cell imaging system. It is a small bright field microscope, equipped with a high-quality 6.4 MP CMOS camera launched to support label-free live cell imaging process.
Global Live Cell Imaging Market: Key Companies Insights
The global live cell imaging market is highly competitive. This is attributed to the increase in adoption of high-content screening techniques in drug discovery, as a result, market players are focusing on launching novel techniques in the market.
Some of the key players in the global live cell imaging market are:
Thermo Fisher Scientific Inc., Merck KgaA, PerkinElmer Inc., Nikon Instruments Inc., Live Cell Instrument, Olympus Corporation, Danaher Corporation, CytoSMART Technologies, ZEISS Group, and Becton, Dickinson and Company, among others.
Live Cell Imaging Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients